Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Upcoming Milestones
Upcoming milestones
Adva-27a Drug Development Program:
>
GMP Manufacturing (5 Kilograms)
IND-Enabling Studies
Filing of IND Application ("Fast-Track" anticipated)
Phase I Clinical Trials (Pancreatic Cancer, Jewish General Hospital)
Antiviral Program:
Efficacy Studies in Coronavirus Infected Mice
.
GMP Manufacturing (5 Kilograms)
Filing of IND Application ("Fast-Track" anticipated)
Phase I Clinical Trials (University of Georgia Affiliate Hospital)
Here is the form https://www.cancer.gov/contact/email-us
Absolutely… will do my part
Sorry to hear your loss… i lost my father in law to AML… hopefully sunshine can stop this in its tracks
Yes there strings to Uncle Sam bucks
Tsoi refused for that reason if I am not mistaken
… hold a spot for me buddy
Yes sir
They are making tacit references to pl4 by saying they discontinued uga due to not “significant” effects on the mice.
Does that mean pl4 has significant effect on mice hence it’s not discontinued?
They are mute on that …
Jmo
Yea looks like their overview only talks of sbfm-pl4
“We are a pharmaceutical and nutritional supplement company focusing on the research and development of proprietary drugs including our anti-cancer compound Adva-27a, and anti-coronavirus lead compound, SBFM-PL4.”
Suweet
Mjp2020 .. thx as always
With you sir
I just copy pasted off Wayne state edu .. I am guessing there might be some adjustments to the date … doesn’t seem far off .., extra info that caught my eye was
“Co-I (20% Effort)”
That means he was co investigator
https://cphs.wayne.edu/sciences/profile/ac6308
“In vivo efficacy and toxicology of SARS-PLpro Leads
Sunshine Biopharma Inc. Co-I (20% Effort), PI = Pegan
$225,404.00 Total Costs
January 1, 2021, to December 31, 2021”
Amen bros
I see huge stage 1 news to fly off otc and stage 2 news to boom in nasdaq and possibly prevent even small RS … jmo
Would love to see adva there
Beautiful
Word … but no fire power :(
https://edtimes.in/sunshine-biopharma-makes-massive-breakthrough-to-tackle-the-deadly-coronavirus/
Sounds like there are multiple compounds with one lead each of which are naphthalene based and human designed
“The compounds which were screened recently are based on the technology described in Sunshine Biopharma’s recently filed patent application covering small molecules which can be used to treat Coronavirus infections. These compounds, naphthalene-based PLpro inhibitors, are shown to be effective at halting SARS-CoV-2 PLpro activity as well as replication. They offer a potential rapid development path to generating PLpro-targeted therapeutics for use against SARS-CoV-2. “
Totally .. e9 brings awareness
hope once these adva and pl4 ducks are lined up … there is a straight buyout
Wow I was not aware of this
This is awesome … thanks
Feel the same
Interesting market cap at 1B
Thanks .. I was confused too .. makes sense … 21% is big share
Yes sir
Right on
It will be a good entry for GSK
Thanks for connecting the dots … makes sense
Amazing catch …
50$… they are going to cry lol